Reminder: DOT expanding drug testing to include opioids on Jan. 1, 2018
Tags : DOT Compliance
The U.S. Department of Transportation (DOT) recently posted an additional notice in anticipation of the upcoming Jan. 1, 2018 effective date.
The notice is available here.
As a reminder, the DOT is expanding their existing drug testing panel – which consists of marijuana, cocaine amphetamines, phencyclidine (PCP) and opiates – to include testing for four semi-synthetic opioids. The four semi-synthetic opioids are hydrocodone, hydromorphone, oxymorphone and oxycodone. Some common names for these semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid® and Exalgo®.
Companies that are covered by the DOT should amend their drug testing programs accordingly prior to Jan. 1, 2018.
Source: Transportation.gov, 12/11/2017
What Our Clients Are Saying
Everyone I have contacted at Certiphi has been a complete pleasure to work with. The Certiphi customer service rivals every other customer service I come in contact with. Everyone is always so professional, yet super nice! Thanks for all you do and keep up the amazing work and impeccable service that you provide!!!
Thank you so much! You have such an incredible reputation within our office; I think we would all say your customer service levels are continually at about 125%!
The response time has been very quick. The turnaround times are great. I love your systems and that I can go in and look at the process as its going.
It’s such a great customer service that you provide and I’m happy to tell that to anyone.
Working with Certiphi has been such a pleasure. Certiphi has taught me so much, not just about backgrounds but also the meaning of great business.
We flew through our NCQA licensure review. We very much appreciate Certiphi's help in earning a 100% score for the files!